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Abstract
Background: Intensive research based on the inverse expression relationship has been undertaken to discover the
miRNA-mRNA regulatory modules involved in the infection of Hepatitis C virus (HCV), the leading cause of chronic
liver diseases. However, biological studies in other fields have found that inverse expression relationship is not the
only regulatory relationship between miRNAs and their targets, and some miRNAs can positively regulate a mRNA
by binding at the 5’ UTR of the mRNA.
Results: This work focuses on the detection of both inverse and positive regulatory relationships from a paired
miRNA and mRNA expression data set of HCV patients through a ‘change-to-change’ method which can derive
connected discriminatory rules. Our study uncovered many novel miRNA-mRNA regulatory modules. In particular, it
was revealed that GFRA2 is positively regulated by miR-557, miR-765 and miR-17-3p that probably bind at different
locations of the 5’ UTR of this mRNA. The expression relationship between GFRA2 and any of these three miRNAs
has not been studied before, although separate research for this gene and these miRNAs have all drawn
conclusions linked to hepatocellular carcinoma. This suggests that the binding of mRNA GFRA2 with miR-557, miR-
765, or miR-17-3p, or their combinations, is worthy of further investigation by experimentation. We also report
another mRNA QKI which has a strong inverse expression relationship with miR-129 and miR-493-3p which may
bind at the 3’ UTR of QKI with a perfect sequence match. Furthermore, the interaction between hsa-miR-129-5p
(previous ID: hsa-miR-129) and QKI is supported with CLIP-Seq data from starBase. Our method can be easily
extended for the expression data analysis of other diseases.
Conclusion: Our rule discovery method is useful for integrating binding information and expression profile for
identifying HCV miRNA-mRNA regulatory modules and can be applied to the study of the expression profiles of
other complex human diseases.
Introduction
HCV is a positive sense single-stranded RNA Hepaci-
virus in the family of Flaviviridae [1]. HCV is capable of
infecting human liver with the contagious and poten-
tially life-threatening liver disease Hepatitis C. It is esti-
mated that HCV has infected approximately 170 million
people worldwide [2], causing a serious public health
problem. The molecular basis of this disease is still
under intensive investigation.
miRNAs, small (~22 nucleotides), endogenous and
highly conserved non-coding RNA molecules [3], play a
pivotal role in cell differentiation, proliferation, growth,
mobility, and apoptosis, as well as in viral replication and
proliferation such as in HCV infections and replication
[4]. miRNAs affect the stability and translational effi-
ciency of target mRNAs by binding to their 3’ untrans-
lated regions (UTRs) to inhibit expression [5]. A miRNA
can have many target mRNAs and a mRNA can be
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regulated by multiple miRNAs, forming complicated
many-to-many regulatory modules between miRNAs and
mRNAs.
The identification of miRNA-mRNA regulatory modules
has proven to be important for understanding complex
cellular systems [5]. It is also useful for understanding the
infection process of human diseases [6]. A recent compu-
tational method based on probabilistic learning has been
specially designed which uses the paired expression pro-
files and binding information of miRNAs and mRNAs of
human cancer samples to discover miRNA-mRNA mod-
ules [7]. Bayesian networks have also been adopted by
many research groups [8,9] to detect novel miRNA-
mRNA modules.
The key idea in all of these studies is the inverse
expression relationship between miRNAs and their target
mRNAs. An inverse expression relationship means that
when the expression level of the miRNA is high (up-
regulated), the target mRNA should be down-regulated
based on the principle that miRNAs deregulate the
expression of targeted mRNAs [10]. However, up-to-date
evidence shows that the inverse relationship does not
always hold. First, a miRNA can induce gene expression
by binding to the gene’s promoter or enhancer sequence.
For example, miR-373 can induce the expression of
E-Cadherin or CSDC2 when binding to these genes’ pro-
moters [11]. Second, recent investigation also shows that
the interaction of miR-10a with RP mRNAs (those
mRNAs encoding ribosomal proteins) binding at their 5’
UTRs can promote the translational enhancement of
these mRNAs instead of repression [12]. Third, some
positively regulated modules of miRNAs and mRNAs
have been studied by wet-labs. For example, Enerly et al.
have reported strong positive correlations between
miRNA clusters and their target genes of distinct biologi-
cal processes in primary human breast tumors [13].
Nazarov et al. have identified several interactions in the
form of negative or positive correlations between miR-
NAs and mRNAs, and subsequently identified positively
correlated miRNA-mRNA interaction networks in the
frontal cortex of mice by differential expression analysis
and weighted gene co-expression network analysis [14].
Therefore, the identified miRNA-mRNA interactions
based purely on the inverse regulatory relationship are
only an incomplete part of the modules in a certain bio-
logical context.
Recently, Zhang et al. (2011) developed a framework
of sparse network-regularized multiple non-negative
matrix factorization (SNMNMF) to discover miRNA-
gene comodules based on factorized coefficient matrices
by integrating diverse data sources [15]. Le et al. (2013)
designed a iterative learning framework of protein inter-
action-based microRNA modules (PIMiM) by combin-
ing sequence, expression and interaction data, which
can perform better than previous methods (including
SNMNMF) [16]. However, both SNMNMF method and
PIMiM method require a predefined dimension of the
matrix factorization (approximately equal to the number
of modules), which may be difficult to determine before-
hand. Additionally, the time complexity of these algo-
rithms is quadratic to both the number of miRNA and
mRNA multiplied by the total number of modules per
iteration. Li et al. (2014) proposed a novel method called
Mirsynergy to detect miRNA regulatory modules
(MiRMs) by integrating mRNA/miRNA expression pro-
files, target site information and gene-gene interaction
to form MiRMs, which can automatically determine the
module number and improve the time complexity [17].
However, these prediction methods often focused on the
anti-correlation modules and ignored the positive regu-
latory relationship in the identified modules.
This work focuses on the detection of both inverse and
positive regulatory relationships in the paired miRNA and
mRNA expression data of HCV-affected tissue samples.
Paired miRNA and mRNA expression profiling provides
an excellent platform for capturing those miRNA expres-
sion changes between two classes of samples that lead,
positively or negatively, to the changes in mRNA expres-
sions between the two classes of samples. We present a
novel two-step sequential method to capture such
‘changes-to-changes’. Our method derives discriminatory
rules from miRNA expression data as the first step, and
derives discriminatory rules from mRNA expression data
as the second step. These rules are then combined to dis-
cover miRNA-mRNA regulatory modules.
The first step works on the miRNA data of the HCV
negative and positive tissue samples to derive differen-
tially expressed miRNAs and discriminatory rules (i.e.,
the miRNA expression changes between the two classes
of samples). For each of these rules, we search for the
predicted mRNA targets of every miRNA from the public
miRNA target database TargetScan [18]. We then narrow
the search findings to a selected mRNA data set by
removing the expression data of those mRNAs which do
not belong to the predicted target mRNAs from the origi-
nal mRNA data set. Discriminatory rules are derived
from this selected and relevant data set of mRNA expres-
sion to concentrate on gene expression patterns that
show significant differences between HCV positive and
negative tissue samples (i.e., the mRNA expression
changes led by those miRNA expression changes
detected in the first step). Then, all the miRNAs in a rule
and the mRNAs involved in the mRNA rules are com-
bined to form a potential miRNA-mRNA regulatory
module which is subsequently analyzed using Pearson’s
correlation coefficients and biological literature results.
Our approach does not use expression similarity net-
works or gene clusters to connect the two expression
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data sets, which differs fundamentally from the tradi-
tional approaches [6,7,19,20] (see Figure 1 for detailed
description).
Methods
miRNA and mRNA expression data sets
The HCV data set from Peng et al. (2009) is used in this
study (downloaded from the NCBI (National Center for
Biotechnology Information) GEO (Gene Expression
Omnibus) database under the SuperSeries accession num-
ber GSE15387). This data set contains 36 tissue samples
(24 HCV positive/+ and 12 HCV negative/-) described by
the expression levels of 470 human miRNAs and 22575
mRNAs. The miRNA and mRNA data sets were both pre-
processed using the Agilent Feature Extraction v9.5.3
under the default miRNA or mRNA parameters. Each
miRNA value is the total gene signal, while each mRNA
value is the log(REDsignal/GREENsignal) per feature (pro-
cessed signals used, base 10). Of the 36 samples, 30 (24
HCV+ and 6 HCV-) samples have paired miRNA and
mRNA expression profiles. Experiments were conducted
on all samples using four technical replicates with the
exception of sample28, sample33 and sample35, for which
only three replicates were used. It is very costly for wet-lab
experiments to obtain such a paired miRNA and mRNA
expression data set. To our best of our knowledge, the
paired data set used in this work is the largest microarray
paired data set in the existing literature.
Discovery of strong discriminatory rules
Given a data set containing two classes of samples (posi-
tive and negative), we discover strong rules in the form:
⋂k
i=1‘ ai ≤ xi ≤ bi, where xi represents a miRNA or a
mRNA, [ai, bi] is the expression range of xi. If every
positive sample’s expression profile satisfies (falls into)
the k specific expression ranges, but none of the nega-
tive sample profiles satisfies, then we say it is a 100%-
frequency rule to differentiate the positive samples from




ai ≤ xi ≤ bi → positive(100%). This
suggests that if the expression of every xi is between ai
and bi for a HCV test sample, then this test sample is
very likely to be a positive sample. Similarly in this
work, we also define the 100%-frequency rule to differ-
entiate negative samples from positive samples. This
study identifies simple 2-miRNA 100%-frequency rules
(i.e., k = 2) to capture differentially expressed miRNAs
and the miRNA expression changes in HCV infection.
We do not identify 3-miRNA 100%-frequency rules or
the rules involving more than 3 miRNAs (i.e., k > 3).
The stringent 100%-frequency may be unnecessary for
other data sets as such distinction may not exist. There-
fore, this frequency requirement can be relaxed for
other studies.
Rule-based identification of miRNA-mRNA regulatory
modules
We take the following steps to detect miRNA-mRNA
regulatory modules. The first step is to use rule discov-
ery to identify differentially expressed miRNA rules of
100%-frequency. Then for every miRNA in each rule,
we obtain its predicted mRNA targets by searching for a
public database [18]. We then construct a selected
Figure 1 Our approach in comparison to previous approaches. We construct miRNA-mRNA regulatory modules using rule-based methods
as shown in the right panel where the mRNA data set is narrowed down by the identified miRNA rules which are derived at the first step.
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mRNA data set for each rule consisting of all the sam-
ples but only those predicted target mRNAs presented
in the original mRNA data set. We subsequently detect
mRNA rules of 100% frequency from this selected
mRNA data set. The mRNA rules and their miRNA rule
are then combined to form a miRNA-mRNA regulatory
module. Our method is summarized in Figure 2 and
detailed in the following subsections.
Rule discovery from miRNA expression data
We rank all of the 470 miRNAs using the gain ratio cri-
teria [21,22] through the Weka 3.6 software package
[23]. The top-ranked miRNAs (the most significant
miRNAs) are then extracted to construct a new data set.
We take a committee tree approach to detect 100%-
frequency rules from this new data set, and to generate
a committee of decision trees. We use the implementa-
tion of the C4.5 algorithm [21] in the R software pack-
age(RWEKA) to construct the tree committee. The first
tree is derived based on the above miRNA data set. To
derive the second tree, we change the data set by
removing the root node of the first decision tree. This
process is repeated until the data set has only two miR-
NAs left. If all of the training samples can be correctly
classified by a rule in one of these trees, then this rule is
a 100%-frequency rule. As mentioned, this work focuses
on only 2-miRNA 100%-frequency rules as differentially
expressed miRNAs for the simple diagnosis of HCV
infection.
All the 100%-frequency rules are evaluated by Eucli-
dean distance [24] and the average area under receiver
operating characteristic (ROC) curves (AUCs) in the
10-fold decision tree cross-validation to determine their
significance. Euclidean distance of a 100%-frequency
rule indicates the separation extent between the HCV+
and HCV- samples. The separation extent is measured
by the shortest pair-wise Euclidean distance of the HCV
+ and HCV- samples (i.e., the Max-Min distance). The
wider the separation is, the more reliable is the rule.
100%-frequency rules with a wide separation distance
are of our interest for a further investigation.
Rule discovery from the mRNA data set
The systematic function of a miRNA is ultimately
defined by its interaction with its target mRNAs or
genes. We thus investigate the co-expressed miRNAs in
each rule and their corresponding target mRNAs that
are corporately involved in HCV infections. For each
rule, we obtain computationally predicted target mRNAs
through the Targetscan database [18]. Using these pre-
dicted target mRNAs and their corresponding expres-
sion profiles from the original mRNA data, we apply
data mining techniques below to discover the rules of
mRNA targets.
Given a dataset D with the class label set C (e.g., posi-
tive and negative), so we detect rules for each c ∈ C.
There may be more than one rule for each c ∈ C, we
use several rounds of rule analysis to detect the rules. In
Figure 2 Computational steps for the identification of miRNA-mRNA regulatory modules. 1) Collection of miRNA expression profile data
set. 2) Discovery of discriminatory rules from the miRNA expression data set using our rule discovery algorithm. 3) Construction of a selected
and relevant mRNA expression data set. 4) Discovery of discriminatory rules from the relevant mRNA data set. 5) Identification of candidate
miRNA-mRNA regulatory modules by combining the miRNAs and mRNAs in the discovered rules.
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each round, we detect a rule for each c ∈ C. We enu-
merate every attribute xi to get its expression range ai
and bi, and calculate the compactness p = Nc/N where
N or Nc is the number of all samples or c’s samples in
the expression range. Then, ai ≤ xi ≤ bi with the highest
compactness is added to the rule. This process is
repeated until (i) p = 100% (a rule for c is detected), or
(ii) p cannot be improved but is still below 100% (there
is no rule for c). In the selected mRNA expression data-
set used in this work, in each round of rule analysis, we
detect two rules: one for HCV+ and the other for HCV-
. For next round, all mRNAs in the discovered rules
beforehand are not considered, and the rule analysis is
performed again to detect more rules. The whole pro-
cess is terminated until none of the classes has a rule.
This computationally heavy method is used at this step,
because it is hard to identify the significant mRNAs
with high gain ratio among tens of thousands of
mRNAs by the tree-based analysis, but this computa-
tional heavy method can work out many 100%-fre-
quency rules from the mRNA data sets.
Rule-based miRNA-mRNA regulatory modules
We group all of its mRNA rules of 100%-frequency for
each miRNA rule. A miRNA-mRNA regulatory module
is formed by using a bipartite graph representation [25],
in which all the mRNAs in these rules comprise the
mRNA partite, while the miRNAs are placed at the
miRNA partite. To show the significant part of the
modules and to assess the modules in the validation, we
focus on the top four mRNA rules: two rules for classi-
fying HCV+ samples and two rules for HCV-. We refer
to these miRNAs and those mRNAs in the top four
rules as significant components of the miRNA-mRNA
regulatory module.
We also review the existing empirical literature to
assess the biological importance of the regulatory mod-
ules. Furthermore, Pearson’s correlation coefficient is
calculated to detect the relationships (positive or nega-
tive correlation) between the miRNAs and mRNAs.
Results
Discriminatory rules from the miRNA expression data
On the original miRNA data set of the 36 samples and
470 miRNAs, the gain ratio method selects 21 top-
ranked miRNAs as the most significant miRNAs for the
distinction between the HCV+ and HCV- samples. Each
of these 21 miRNAs has a gain ratio >0.5. The other
miRNAs have a gain ratio ≤ 0.5 and thus were not con-
sidered for further study here. Statistical analysis is also
carried out using the two-sided student’s t-test and the
statistical significance is set as P < 0.05 (Table 1).
On the data set of the above 21 miRNAs and all of
the 36 samples, a total of nine 100%-frequency rules
covering 10 miRNAs are derived through our committee
tree approach. Each of these rules can classify the 36
samples into HCV+ or HCV- without any misclassifica-
tion. An example of these miRNA rules is related to
miR-557 and miR-214. The rule is that: every HCV+
sample’s expression profile satisfies the two miRNAs’
specific expression ranges: 8.94 ≤ miR − 557 ≤ 43.53 ∩
95.54 ≤ miR − 214 ≤ 1057.51, but none of the HCV-
samples satisfies these two expression ranges. The mini-
mum Euclidean distance separating the two classes of
samples for each rule and the average AUCs in the 10-
fold decision tree cross-validation are also calculated. As
shown in Table 2 the rule consisting of miR-557 and
miR-214 has the maximum distance and maximum
AUC.
Rules from the mRNA expression data
For each miRNA rule, the predicted mRNA targets from
TargetScan are used to narrow down the original
mRNA data set to a relevant mRNA data set for mRNA
rule discovery. As shown in Table 3 some of the pre-
dicted targets (mRNAs) of a miRNA are not in the list
of the probes used in the original mRNA expression
data set (Table 2). Therefore, the mRNA expression pro-
files of only those targets (mRNAs) of the miRNAs in
the probe list are used for the rule discovery (forth col-
umn of Table 2). We note that the miRNAs involved in
each rule may have common targets. For example, miR-
557 and miR-214 have two common targets. On the 9
new mRNA data sets each for one miRNA rule, many
100%-frequency rules were mined by our proposed rule
mining method (Table 2). In detail, we identified 28
mRNA rules for HCV+ and 145 mRNA rules for HCV-
covering a total of 1118 mRNAs for all of the 9 miRNA
rules (Table 2). Lastly, the top 4 rules, 2 from HCV+
(one rule is used if it is only one mRNA rule in HCV+)
and 2 from HCV- are chosen as differentially expressed
mRNAs for the subsequent miRNA-mRNA regulatory
module study.
Table 1 The top-ranked miRNAs with gain ratio larger
than 0
miRNA Rank p-value miRNA Rank p-value
miR-202 1 2.072e-08 miR-519e* 12 4.222e-04
miR-601 2 1.060e-05 miR-526b 13 8.246e-04
miR-498 3 6.196e-09 miR-345 14 9.802e-05
miR-557 4 1.148e-05 miR-17-3p 15 2.927e-05
miR-34a 5 1.767e-02 miR-520a 16 0.276
miR-493-3p 6 3.127e-06 miR-452 17 4.170e-05
miR-214 7 4.629e-03 miR-501 18 4.328e-07
miR-184 8 1.470e-06 miR-130a 19 7.261e-04
miR-129 9 3.752e-03 miR-34b 20 1.278e-02
miR-765 10 1.243e-08 miR-221 21 4.622e-02
miR-210 11 1.668e-08
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A miRNA-mRNA regulatory interaction network
The above detected miRNA rules and significant mRNA
rules are merged to form 9 miRNA-mRNA regulatory
modules. These 9 miRNA-mRNA regulatory modules
are then integrated to form a bigger miRNA-mRNA reg-
ulatory network (Figure 3). Many miRNAs and mRNAs
with bold in these modules are related to diseases, in
particular hepatocellular carcinoma, as supported in the
literature (Table 4).
The numbers of mRNAs in these significant modules
are shown in the last column of Table 2. Figure 4 and 5
show two examples of these significant modules, and all
the miRNAs in bold and the mRNAs with underline
and italics can be confirmed by the literature. The vali-
dation results are presented below:
• In the module for miR-557 and miR-214 (Figure 4),
miR-557 has been reported as a novel candidate bio-
marker for hepatocellular carcinoma [26], and miR-
214-5p has been shown to up-regulate in human and
mouse livers in a fibrosis progression-dependent
manner. The expression of miR-214-5p increased
during the culture-dependent activation of mouse
primary stellate cells and was significantly higher in
stellate cells than in hepatocytes [27]. As miR-214
and miR-557 expression patterns in hepatocellular
carcinoma are tissue specific, they can both serve as
novel biomarkers for chronic liver diseases. Mean-
while, a target mRNA ACVR1C of miR-557 is also
associated with a reduction in HCV-infected cells
[28], while the target mRNA RAB43 of miR-214, a
key RAB to maintain a functional Golgi complex in
human cells [29], has been found to interact with
HCV NS5A proteins [30] and can also mediate the
replication of HCV [29].
• In the module of miR-34a and miR-214, besides
the confirmed miR-214 and its mRNA RAB43, miR-
34a has been reported to upregulate in both liver
fibrosis and hepatocellular carcinoma, and serum
levels of miR-34a are significantly higher in chronic
hepatitis C infection patients than in controls [31].
In addition, its target mRNA Fibronectin (FNDC5 )
was down-regulated and associated with hepatic
fibrosis [32].
• In the module of miR-493-3p and miR-214, the
sole target mRNA WDR33 of miR-493-3p has been
found to result in increased viral infection with two
or more siRNAs [33].
• In the module of miR-184 and miR-214, a mRNA
ALDH4A1 of miR-184 was believed to contribute to
HBV- or HCV- induced liver [34].
• In the module of miR-129 and miR-765 (Figure 5),
miR-129 has been strongly believed to be involved in
the significant dysregulation in hepatocellular carci-
nogenesis [26,35], and miR-765 is one of promising
candidate miRNA biomarkers to detect hepatocellular

















R1 4.8946 0.9323 300 HCV+ 2 14 110 15
R2 3.2888 0.9323 517 HCV+ 2 21 159 12
R3 2.5160 0.9323 329 HCV+ 2 14 85 12
R4 2.3360 0.8889 247 HCV+ 2 11 75 12
R5 0.2256 0.8681 184 HCV+ 2 5 41 13
R6 1.6425 0.9115 650 HCV- 8 34 269 10
R7 1.2757 0.8750 398 HCV- 7 28 227 10
R8 2.6420 0.9028 186 HCV- 2 6 55 20
R9 0.9806 0.8958 289 HCV- 1 12 97 11
R1: miR-557 and miR-214; R2: miR-34a and miR-214; R3: miR-493-3p and miR-214; R4: miR-214 and miR184; R5: miR-184 and miR-210; R6: miR-129 and miR-765;
R7: miR-765 and miR-210; R8: miR-210 and miR-452; R9: miR-452 and miR-17-3p. 1 : the miRNA rule defines a region covering all samples of a class.
2(3): the number of mRNA rules, each of which defines a region covering all samples of HCV+(HCV-).
4: the number of mRNAs in the top four mRNA rules: the top two mRNA rules in HCV+ (one rule is used if it is the only mRNA rule in HCV+) and another top two
rules in HCV-.
Table 3 Predicted targets in the TargetScan and those
targets common in our data set.
miRNA mRNA targets
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Figure 3 A miRNA-mRNA regulatory interaction network. There is an edge between two miRNAs if they are components of a miRNA rule.
The edge between a miRNA and a mRNA represents a regulation of the miRNA for its target. Six miRNAs (miR-214, miR-34a, miR-129, miR-765
and miR-210) and 9 mRNAs (ACVR1C, RAB43, FNDC5, WDR33, ALDH4A1, ANKRD12, KCTD9, ARMC1 and DICER1) all in red are confirmed by
literature work.
Table 4 All target mRNAs of miRNAs in HCV+ and HCV- modules
miRNAs Targeted mRNAs modules
miR-557 ADRA1D, ACVR1C, DNAJA3, FAM120A HCV+
miR-214 ASB16, GALNTL4, CBX5, BNC2, PDLIM2,RAB43, SPCS2, NKTR, ASXL1, ACLY,C6orf192, ING4, GLG1, SHOC2 HCV+
miR-34a CPLX2, FNDC5 HCV+
miR-493-3p WDR33 HCV+
miR-184 EPB41L5, ALDH4A1 HCV+
miR-129 CBLB, OCRL, COMT, DENND2C HCV-
miR-765 ABCC5, BRD3, ANKRD12, AUTS2, PCID2, NMD3, NUP43 HCV-/+
miR-210 FGD4, HDAC4, CACNA2D2, OAZ2, ADAMTS5, AK3, CDKN1B, EPM2AIP1, PPP1R12B, PRPF4B, STAM2, EZ6L, SAMD4A, PISD,
KCTD9, FAM118A, CHD2, KIT, TCF4
HCV-
miR-452 ARMC1, ZNF462, EFNA3, SMG5, FAM73B HCV-
miR-17-3p BNC2, DICER1, GFRA1, KIAA1804, ENPP1, ZNF558, ERO1L, SNX27, ZNF718 HCV-
Song et al. BMC Genomics 2015, 16(Suppl 2):S11
http://www.biomedcentral.com/qc/1471-2164/16/S2/S11
Page 7 of 14
carcinoma among hepatitis C virus patients [36].
Meanwhile, mRNA ANKRD12 of miR-765 is involved
in one of the important roles of host miRNAs in reg-
ulating the liver-specific HCV [37].
• In the module of miR-765 and miR-210, besides the
validation of miR-765 and its target mRNAs above,
miR-210 was upregulated in HBV-producing
HepG2.2.15 cells compared to parental HepG2 cells,
and identified to suppress hepatitis B virus [38]. In
addition, a target mRNA (KCTD9) of miR-210 has
been found to make contribution to liver injury [39].
Other mRNAs in these modules are also confirmed to
be involved in hepatocellular diseases. For example, a
mRNA of miR-452, ARMC1 is up-regulated and fre-
quently amplified in human hepatocellular carcinoma
[40]. Target mRNA DICER1 of miR-17-3p, a component
of the RNAi machinery, can markedly reduce HCV pro-
duction and intracellular HCV RNA levels [41].
All these validation results suggest that the identified
modules are closely related to hepatocellular carcinoma
and are novel knowledge for understanding the miRNA-
mRNA regulation in the host responses and pathogen-
esis of HCV infection.
Many-to-many miRNA-mRNA regulatory modules
The big regulatory module (Figure 3) is a miRNA-mRNA
interaction network integrated from the 9 simple regula-
tory modules corresponding to the 9 miRNA rules. A
many-to-many miRNA-mRNA regulatory module usually
consists of a cohort of miRNAs and a set of their target
mRNAs, in which a target mRNA is regulated by multiple
Figure 4 The regulatory module inferred from the first miRNA rule and its corresponding mRNAs. miR-557 and miR-214, the miRNAs of
the first HCV+ miRNA rule are placed at the up panel. Four mRNA rules are identified and their mRNAs are placed at in the middle and bottom
panels. The edges linking miR-214 and its mRNA targets are in solid lines, while the edges linking miR-557 and its mRNA targets are in dashed
lines. The confirmed target mRNAs are also highlighted with an underline.
Figure 5 The regulatory module inferred from the first HCV- rule consisting of miR-129 and miR-765. In this module, miR-765 targets 6
mRNAs and miR-129 regulates 4 mRNAs. ANKRD12, a target of miR-765, is validated to be associated with chronic liver disease by existing works.
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miRNAs, and a miRNA has multiple mRNAs as its target.
We specially examined those many-to-many miRNA-
mRNA regulatory modules in which mRNAs are targeted
by at least 3 miRNAs. Figure 6 shows such an example.
This regulatory module contains 8 miRNAs and 6 tar-
get mRNAs. The literature shows that the miRNAs in
this regulatory module are causally connected to human
hepatocellular carcinoma or related diseases. For exam-
ple, miR-129, miR-214 and miR-34a are found to associ-
ate with human hepatocellular carcinoma [26,31,35,42].
Mature miR-184 of over-expression can act as an onco-
gene in the antiapoptotic and proliferative processes of
tongue Squamous Cell Carcinoma [43]. miR-129 can reg-
ulate multiple tumor cell lines and primary tumors
including medulloblastoma, undifferentiated gastric can-
cers, lung adenocarcinoma, endometrial cancer and col-
orectal carcinoma through down-regulating CDK6
expression [44]. miR-34a can act as a tumor suppressor
gene in a broad range of tumors including breast cancer,
lung cancer, colon cancer, kidney cancer, bladder cancer
and pancreatic carcinoma cell lines [45]. The mRNAs
targeted by the miRNAs in this regulatory module are
also engaged with cancer. Tumor suppressor QKI (the
common target of miR-493-3p, miR-129 and miR-765) is
expressed at significantly low levels in most of the gastric
cancer tissues [46]. MAP2 has been reported to be
involved with malignant oral cancer tissues by playing
important roles in neuronal and non-neuronal develop-
ment [47].
Negatively and positively regulated mRNAs by multiple
miRNAs
The miRNA-mRNA expression relationships in the
above many-to-many regulatory module were further
assessed by analysing the Pearson’s correlation coeffi-
cients of the 19 paired miRNA and mRNA expression
levels of the 30 patients (i.e., the 19 edges in Figure 6).
These coefficients are shown in Table 5. As expected,
most of these relationships are negative. For example,
QKI, MAP2 and BNC2 have an inverse expression
relationship with all of their regulator miRNAs.
FRMPD4 is also negatively correlated with their regula-
tors except for miR-493-3p. CAMK2D has a random
correlation with miR-129 and miR-214, but it is nega-
tively correlated with miR-17-3p.
One of our novel findings is a positive regulatory rela-
tionship between a mRNA and multiple miRNAs. As can
be seen from Table 5, GFRA2 has a clear positive rela-
tionship with the expression of all of miR-557, miR-765
and miR-17-3p with Pearson’s correlation coefficients
0.18, 0.21, and 0.26 respectively. Figure 7 details these
positively regulated expression levels of GFRA2 of the 30
patients in comparison with the expression levels of the
three miRNAs. As indicated by the gain ratios shown in
Table 1, the expression levels of each of these three miR-
NAs are able to separate these HCV+ and HCV- samples
(also seen from the horizontal lines in Figure 7). It is the
expression change of these three miRNAs that leads to a
positive expression change of GFRA2 between the two
classes of patients.
The sequence matching between these miRNAs and
GFRA2 was also studied. Ørom et al. reported that the
binding of miR-10a at the 5’ UTRs of ribosomal protein
(RP) mRNAs can promote their translational enhance-
ment instead of repression [12]. We attempted to verify
whether the 5’ UTR of GFRA2 has a full or partial com-
plementary sequence pairing with the seed region of
miR-557, miR-765 or miR-17-3p. The fact is that the
seed region of these three miRNAs is complementary to
the 5’ UTR of GFRA2 with just one mismatched pair. In
detail, the seed region of miR-557 matches the positions
from 132 to 138 of GFRA2 5’ UTRs, the seed region of
miR-17-3p matches from 225 to 231, and the seed
region of miR-765 matches from 495 to 502 (Figure 8).
Therefore, it is likely that these three miRNAs bind at
the 5’ UTR end of GFRA2 mRNA to enhance its transla-
tion for a positive regulation.
The statistical significance of this sequence comple-
mentarity in the defined manner (which includes a mis-
match) was analyzed using a Markov Model (MM) [48].
Figure 6 The many-to-many relationship between some mRNAs and miRNAs identified in our modules. One mRNA are targeted by
many miRNAs and one miRNA can regulate many mRNAs
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Based on first-order Markov model [49], the comple-
mentary significance was assessed by computing a prob-
ability (P) for each miRNA-5’ UTR pair. It is an
approximate probability that a complementary to the
miRNA seed is found in the corresponding 5’ UTR. The
lower the P is, the higher the chances that the 5’ UTR is
a functional target. The length of the 5’ UTR of GRFA2
mRNA is 675, composed of 151 purine bases adenine
(A), 182 guanine (G), 161 the pyrimidine bases uracil
(U), and 181 cytosine (C). The number of nucleotide in
the miRNA seed region is 7. The transition matrix is
shown as in Table 6. The complementary probability of
the sequence matching between the seed region of the
three miRNAs (miR-557, miR-765 and miR-17-3p) and
the 5’ UTRs of GFRA2 are 1.337e-05, 1.488e-04, and
1.133e-04 respectively which all imply a strong indica-
tion of a functional target.
To the best of our knowledge, the expression relation-
ship between GFRA2 and any of the three miRNAs has
not been studied before in spite of intensive separate
research for this mRNA or these miRNAs. GFRA2 is a
member of the GDNF receptor family encoding GDNF
family receptor alpha-2 protein. GFRA2 is also a glyco-
sylphosphatidylinositol (GPI)-linked cell surface receptor
for both the Glial cell line-derived neurotrophic factor
(GDNF) and neurturin (NTN) [50], and it can affect the
activation of the RET tyrosine kinase receptor [51].
GFRA2 is a candidate gene for RET-associated diseases.
Brain-derived neurotrophic factor in patients has been
found to be related with Chronic Hepatitis C [52]. Inde-
pendent of the research on GFRA2, miR-557 [26], miR-
765 [36] and miR-17-3p [53] all have been reported to
associate with hepatocellular carcinoma. This suggests
that the binding and interaction of mRNA GFRA2 with
miR-557, miR-765, or miR-17-3p, or with their combi-
nations is a new research area, worthy of comprehensive
investigation by wet-lab experiments.
We also closely examined a strong negative regulatory
relationship, shown in Figure 6. This regulatory relationship
Table 5 Pearson’s correlation coefficients between the
miRNAs and mRNAs in the many-to-many regulatory
module
GFRA2 QKI MAP2 FRMPD4 BNC2 CAMK2D
miR-493-3p - -0.68 - 0.12 - -
miR-184 - - - -0.05 - -
miR-129 - -0.71 - - - 0.01
miR-214 - - -0.15 - -0.01 0.03
miR-557 0.18 - -0.01 - - -
miR-765 0.21 -0.44 -0.02 -0.04 -0.10 -
miR-17-3p 0.26 - - - -0.13 -0.13
miR-34a - - -0.05 - - -
(Figure 8).’-’ indicates the mRNA (in a column) is not the target of the miRNA
(in a row)
Figure 7 The positive expression relationship between GFRA2 mRNA and miR-557, miR-765, and miR-17-3p. The expression levels of the
three miRNAs are preprocessed in the log scale, and the expression levels of GFRA2 are expanded by 10 times. The three miRNAs all have a high
gain ratio, separating the HCV+ and HCV- samples very well.
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is between QKI mRNA and multiple miRNAs miR-493-3p,
miR-129 and miR-765 (see Figure 9). The seed matching
sequence of miR-129 is located within the 3’ UTRs end of
QKI. But, the 5’ UTRs of QKI mRNA does not contain the
miR-129 complementary seed site. It is believed that miR-
129 binds at the 3’ UTRs end of QKI mRNA to down regu-
late its translation.
Pearson ’s correlation coefficients were similarly
examined for the literature-confirmed miRNAs and
their corresponding mRNAs in Figure 3. It was found
that miR-17-3p and DICER1 mRNA have a strong
negative regulatory relationship (Pearson’s correlation
coefficient: -0.53). A protein possessing an RNA heli-
case motif can be encoded by DICER1 gene. The
encoded protein functions as a ribonuclease and is
required to produce the active small RNA component
that represses gene expression, which may affect the
biogenesis of miRNA [54].
As found by this work, the strongest positively regu-
lated relationship is between miR-184 and ALDH4A1
mRNA. Its Pearson’s correlation coefficient is 0.43
(Figure 10). The ALDH4A1 mRNA is up-regulated in
late HCV cirrhosis [55] and HBV pathogenesis [34]. In
Drosophila, a luciferase reporter assay has shown that
miR-184 can target some mRNAs in the protein coding
region [56]. We found that the seed region of miR-184
is complementary to the coding region or to the 5’ UTR
of ALDH4A1 with just one mismatched pair. The seed
region of miR-184 matches the positions from 705 to
711 of ALDH4A1 ’s coding region or with the positions
from 257 to 263 at ALDH4A1 5’ UTR. Based on this
evidence, the miRNA-184 target sites in 5’ UTRs or cod-
ing region may make significant contribution to miR-
184 mediated regulation. The functionality of miR-184
when binding at the 5’ UTR or the coding region of
ALDH4A1 deserves thorough investigation to expand
the current research on the 3’ UTR only.
We also found other evidence supports that ectopic
expression of miRNA-184 leads to neuroblastoma cell
growth arrest and apoptosis, miRNA-184 expression is
repressed in human neuroblastoma tissues, and low
levels of miRNA-184 expression in human neuroblas-
toma tissues correlate with poor patient survival [57].
We next made use of the publically available Versteeg
microarray gene expression dataset http://r2.amc.nl,
which contained both gene expression levels and patient
prognosis. Kaplan-Meier analysis showed that low levels
of ALDH4A1 mRNA expression in human neuroblas-
toma tissues positively correlated with poor patient
prognoses (p ¡ 0.01). As low levels of miR-184 in human
neuroblastoma tissues also correlates with poor patient
survival, the data suggest that miR-184 is likely to posi-
tively regulate ALDH4A1 expression in tumours.
In addition, we also checked our discovery results in
the miRTarbase database [58,59] and starBase database
[60,61], an interaction between miR-214 and ING4
mRNA (Table 4) in the miRTarbase database is experi-
mentally validated by reporter assay and quantitative
polymerase chain reaction (qPCR). Another interaction
is confirmed between hsa-miR-129-5p (previous ID: hsa-
miR-129) and QKI in the starBase database, with the
highest Pearson’s Correlation Coefficient in Table 5.
Conclusion
In this work, we have proposed rule-based methods for
the discovery of miRNA-mRNA regulatory modules in
Figure 8 The partial complementary sequence pairing. The 5’ UTRs of GFRA2 contains the seed sites of miR-557, miR-765 and miR-17-3p. The
mismatched base pairs are shown in smaller font.
Table 6 Transition probability of two adjacent bases in
the 5’ UTRs of GFRA2
A G U C Sum
A 33 (0.219) 50 (0.331) 32 (0.212) 36 (0.238) 151 (1.000)
G 60 (0.330) 60 (0.330) 20 (0.110) 42 (0.230) 182 (1.000)
U 22 (0.137) 33 (0.205) 62 (0.385) 44 (0.273) 161 (1.000)
C 36 (0.199) 38 (0.210) 47 (0.260) 60 (0.331) 181 (1.000)
Sum 151 (0.885) 181 (1.076) 161 (0.967) 182 (1.072) 675 (4.000)
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Figure 9 An example of the negative expression relationship. An negative relationship between the QKI mRNA and miR-493-3p, miR-129,
and miR-765. The expression levels of the three miRNAs are preprocessed in the log scale. The three miRNAs all have a good gain ratio,
separating the HCV+ and HCV- samples very well.
Figure 10 An example of the positive expression relationship. An positive realtionship between the ALDH4A1 mRNA and miR-184. The
expression levels of miR-184 is preprocessed by dividing 10 and has a good gain ratio, classifying the HCV+ and HCV- samples very well.
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HCV infection. We followed the biological principle that
inverse expression relationships and positively regulated
miRNA-mRNA pairs can both exist in many-to-many
regulatory modules. We detected 100%-frequency rules
from the most differentially expressed miRNAs and then
mined 100%-frequency rules from the relevant target
mRNAs expression data for each miRNA rule. We inte-
grated the miRNA rules and their mRNA rules to con-
struct miRNA-mRNA regulatory modules. Many
detected miRNAs and mRNAs can be supported by
recent work in the literature. We also detected novel
positive and inverse regulatory relationships. For exam-
ple, mRNA GFRA2 is positively regulated by multiple
miRNAs miR-557, miR-765 and miR-17-3p which all
likely bind at the 5’ UTR end of GFRA2. The detected
miRNA-mRNA regulatory modules will provide new
insights into the regulation of host responses and the
pathogenesis of HCV infection. We conclude that our
rule discovery method is useful for integrating binding
information and expression profile for identifying HCV
miRNA-mRNA regulatory modules and can be applied
to the study of the expression profiles of other complex
human diseases.
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